Skip to main content

Table 5 Functional enrichment of genes expressed lower in blood of breast cancer patients compared to healthy subjects

From: Gene expression profiling of peripheral blood cells for early detection of breast cancer

Biological process

Count

%

P-Value

Genes

Fold Enrichment

FDR

GO:0044255 Cellular lipid metabolic process

20

7.69%

0.0008

C10orf33, MBTPS1, PMVK, OSBPL7, SULT1A2, PEMT, LASS6, CMAS, SYK, PLAA, SULT1A4, INSIG1, IDI1, FDPS, HEXA, PECI, CYP2J2, ACAA1, SULT1A1, GRN,

2.3

1.6

GO:0008202 Steroid metabolic process

9

3.46%

0.0022

INSIG1, IDI1, MBTPS1, FDPS, PMVK, OSBPL7, SULT1A2, SULT1A1, SULT1A4,

3.8

4.0

GO:0006629 Lipid metabolic process

21

8.08%

0.0027

C10orf33, MBTPS1, ACAT2, PMVK, OSBPL7, SULT1A2, PEMT, LASS6, CMAS, SYK, PLAA, SULT1A4, INSIG1, IDI1, FDPS, HEXA, PECI, CYP2J2, ACAA1, SULT1A1, GRN,

2.1

4.9

GO:0006584 Catecholamine metabolic process

4

1.54%

0.0057

SULT1A2, HDC, SULT1A1, SULT1A4,

10.3

10.1

GO:0018958 Phenol metabolic process

4

1.54%

0.0057

SULT1A2, HDC, SULT1A1, SULT1A4,

10.3

10.1

  1. FDR = false discovery rate